了解疫苗供应死亡空间和浪费的COVID-19疫苗剂量之间的关系
Yago Marcos Pessoa-Gonçalves1, Ana Lucia Gonçalves de Jesus2, Chamberttan Souza Desidério1
1Universidade Federal do Triângulo Mineiro, Instituto de Ciências Biológicas e Naturais, Laboratório de Imunologia e Bioinformática, Uberaba, MG, Brasil.
Revista da Sociedade Brasileira de Medicina Tropical
|October 4, 2023
概括
供应中的COVID-19疫苗死空间导致巴西大量的剂量浪费. 尽量减少这种死亡空间对于保存有价值的疫苗剂量至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
- 制药科学 制药科学
背景情况:
- 截至2023年7月,巴西已经注射了超过5.4亿剂COVID-19疫苗.
- 由于注射用品中的残留体积,导致了大量的疫苗浪费.
研究的目的:
- 为了量化COVID-19疫苗剂量由于供应中死空间而浪费的数量.
- 评估注射器死空间对整体疫苗浪费的影响.
主要方法:
- 疫苗供应在充满蒸水之前和之后被称重,以确定死亡空间体积.
- 用描述性分析计算了疫苗浪费率和总浪费剂量.
主要成果:
- 估计有62,097,338个COVID-19疫苗剂量在使用最小死空间的供应时被浪费.
- 注射器死空间被确定为剂量浪费的主要原因.
结论:
- 疫苗供应中的死空间是直接影响浪费剂量数量的关键因素.
- 解决注射器死空间对于优化疫苗分配和最大限度地减少浪费至关重要.
相关概念视频
Vaccinations
44.6K
Overview
44.6K
Cancer Vaccines
389
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
389


